Choisissez la langue de votre document :
- bg - български
- es - español
- cs - čeština
- da - dansk
- de - Deutsch
- et - eesti keel
- el - ελληνικά
- en - English (sélectionné)
- fr - français
- ga - Gaeilge
- hr - hrvatski
- it - italiano
- lv - latviešu valoda
- lt - lietuvių kalba
- hu - magyar
- mt - Malti
- nl - Nederlands
- pl - polski
- pt - português
- ro - română
- sk - slovenčina
- sl - slovenščina
- fi - suomi
- sv - svenska
 |
| Parliamentary questions |
| |||
| 2 September 2019 |
| |||
| Question for written answer E-002599-19 to the Commission Rule 138 Pascal Arimont (PPE) | ||||
 Subject: Research into myalgic encephalomyelitis (ME) |
| |||
|
Chronic fatigue syndrome (CFS), or myalgic encephalomyelitis (ME), is a chronic condition that affects many people, but little is known about its precise causes. To date, no recognised ways of properly diagnosing and treating the condition exist. Does the EU provide funds for research into this condition so that diagnosis and treatment can be improved? What practical steps is the EU taking to improve our knowledge of ME/CFS? | ||||
| ||||
| Dernière mise à jour: 18 septembre 2019 | Avis juridique - Politique de confidentialité |